Prelude Capital Management, LLC Amyris, Inc. Transaction History

Prelude Capital Management, LLC

  • $1.57 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$1.52 - $3.39 $198,470 - $442,642
130,573 New
130,573 $199,000
Q2 2022

Aug 15, 2022
SELL
$1.6 - $5.07 $2,145 - $6,798
-1,341 Reduced 0.65%
205,839 $381,000
Q1 2022

May 16, 2022
BUY
$3.92 - $5.86 $812,145 - $1.21 Million
207,180 New
207,180 $903,000
Q3 2021

Nov 15, 2021
SELL
$12.13 - $16.99 $145,560 - $203,879
-12,000 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$10.82 - $19.37 $129,840 - $232,440
12,000 New
12,000 $196,000

Others Institutions Holding AMRS

# of Institutions
7
Shares Held
230K
Call Options Held
0
Put Options Held
0
View Full List

About AMYRIS, INC.

AMRS Quotes by TradingView
  • Ticker AMRS
  • Exchange NASDAQ
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 324,860,000
  • Market Cap $3.25M
  • Description
  • Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...
More about AMRS
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email